Polyrizon (PLRZ) Competitors $1.07 0.00 (-0.07%) As of 02:58 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock PLRZ vs. RLYB, LEXX, MIRA, PMN, PASG, MTVA, NNVC, ALLR, SNYR, and CASIShould you be buying Polyrizon stock or one of its competitors? The main competitors of Polyrizon include Rallybio (RLYB), Lexaria Bioscience (LEXX), MIRA Pharmaceuticals (MIRA), Promis Neurosciences (PMN), Passage Bio (PASG), MetaVia (MTVA), NanoViricides (NNVC), Allarity Therapeutics (ALLR), Synergy CHC (SNYR), and CASI Pharmaceuticals (CASI). These companies are all part of the "pharmaceutical products" industry. Polyrizon vs. Its Competitors Rallybio Lexaria Bioscience MIRA Pharmaceuticals Promis Neurosciences Passage Bio MetaVia NanoViricides Allarity Therapeutics Synergy CHC CASI Pharmaceuticals Polyrizon (NASDAQ:PLRZ) and Rallybio (NASDAQ:RLYB) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, profitability, valuation, institutional ownership, earnings, media sentiment, risk and dividends. Is PLRZ or RLYB more profitable? Polyrizon has a net margin of 0.00% compared to Rallybio's net margin of -5,473.33%. Polyrizon's return on equity of 0.00% beat Rallybio's return on equity.Company Net Margins Return on Equity Return on Assets PolyrizonN/A N/A N/A Rallybio -5,473.33%-71.66%-65.06% Do insiders & institutionals hold more shares of PLRZ or RLYB? 90.3% of Rallybio shares are owned by institutional investors. 8.7% of Rallybio shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Does the media prefer PLRZ or RLYB? In the previous week, Polyrizon had 3 more articles in the media than Rallybio. MarketBeat recorded 6 mentions for Polyrizon and 3 mentions for Rallybio. Rallybio's average media sentiment score of 0.64 beat Polyrizon's score of 0.63 indicating that Rallybio is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Polyrizon 1 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Rallybio 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has stronger earnings and valuation, PLRZ or RLYB? Polyrizon has higher earnings, but lower revenue than Rallybio. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPolyrizonN/AN/A-$1.54MN/AN/ARallybio$640K36.96-$57.78M-$0.94-0.60 Do analysts rate PLRZ or RLYB? Rallybio has a consensus price target of $5.00, suggesting a potential upside of 783.39%. Given Rallybio's stronger consensus rating and higher possible upside, analysts clearly believe Rallybio is more favorable than Polyrizon.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Polyrizon 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Rallybio 0 Sell rating(s) 4 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 SummaryRallybio beats Polyrizon on 6 of the 11 factors compared between the two stocks. Get Polyrizon News Delivered to You Automatically Sign up to receive the latest news and ratings for PLRZ and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding PLRZ and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PLRZ vs. The Competition Export to ExcelMetricPolyrizonMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$6.40M$3.07B$5.65B$10.30BDividend YieldN/A2.36%5.68%4.61%P/E RatioN/A20.8575.8526.09Price / SalesN/A397.84514.78169.46Price / CashN/A45.9137.5661.52Price / Book0.009.6212.886.30Net Income-$1.54M-$52.73M$3.29B$271.03M7 Day Performance2.82%0.77%-0.25%-0.14%1 Month Performance4.83%6.48%3.88%6.44%1 Year PerformanceN/A19.04%68.42%28.85% Polyrizon Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PLRZPolyrizonN/A$1.07-0.1%N/AN/A$6.40MN/A0.00N/ARLYBRallybio3.1547 of 5 stars$0.59+3.6%$5.00+748.9%-46.3%$24.57M$640K-0.6340News CoverageGap DownLEXXLexaria Bioscience3.6919 of 5 stars$1.26+3.7%$4.00+218.7%-54.5%$24.55M$460K-1.877Gap DownMIRAMIRA Pharmaceuticals2.9144 of 5 stars$1.28-1.2%$17.00+1,233.3%+21.6%$24.31MN/A-2.602Positive NewsPMNPromis Neurosciences3.4574 of 5 stars$0.46+0.2%$4.33+850.3%-68.1%$23.62MN/A-2.175News CoveragePASGPassage Bio3.9104 of 5 stars$7.41+5.4%$75.67+921.1%-39.2%$23.56MN/A-0.41130Positive NewsMTVAMetaVia2.2433 of 5 stars$0.95-10.4%$7.50+689.6%N/A$22.99MN/A0.008NNVCNanoViricides0.0947 of 5 stars$1.43-1.0%N/A-2.1%$22.90MN/A-1.9820ALLRAllarity Therapeutics2.2221 of 5 stars$1.56+6.1%$9.00+476.9%-26.6%$22.81MN/A0.0010SNYRSynergy CHC3.98 of 5 stars$2.39+6.2%$10.00+318.4%N/A$22.56M$34.83M6.2940CASICASI Pharmaceuticals3.8176 of 5 stars$1.83-4.5%$4.00+119.2%-71.3%$22.45M$31.56M-0.63180 Related Companies and Tools Related Companies Rallybio Alternatives Lexaria Bioscience Alternatives MIRA Pharmaceuticals Alternatives Promis Neurosciences Alternatives Passage Bio Alternatives MetaVia Alternatives NanoViricides Alternatives Allarity Therapeutics Alternatives Synergy CHC Alternatives CASI Pharmaceuticals Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PLRZ) was last updated on 9/25/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Polyrizon Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Polyrizon With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PLRZ Stock Alerts